Avoro Capital Advisors LLC Invests $256.05 Million in SPDR S&P Biotech ETF $XBI

Avoro Capital Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 2,100,000 shares of the exchange traded fund’s stock, valued at approximately $256,053,000. SPDR S&P Biotech ETF makes up approximately 2.5% of Avoro Capital Advisors LLC’s portfolio, making the stock its 14th biggest holding.

Several other large investors have also modified their holdings of the stock. Blair William & Co. IL boosted its stake in shares of SPDR S&P Biotech ETF by 1.0% during the 4th quarter. Blair William & Co. IL now owns 102,867 shares of the exchange traded fund’s stock worth $12,543,000 after acquiring an additional 1,057 shares in the last quarter. OMERS ADMINISTRATION Corp boosted its stake in shares of SPDR S&P Biotech ETF by 42,425.3% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after acquiring an additional 1,187,907 shares in the last quarter. Tamar Securities LLC boosted its stake in shares of SPDR S&P Biotech ETF by 24.2% during the 4th quarter. Tamar Securities LLC now owns 65,763 shares of the exchange traded fund’s stock worth $8,018,000 after acquiring an additional 12,800 shares in the last quarter. Sargent Investment Group LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $569,000. Finally, MML Investors Services LLC boosted its stake in shares of SPDR S&P Biotech ETF by 14.4% during the 4th quarter. MML Investors Services LLC now owns 25,627 shares of the exchange traded fund’s stock worth $3,125,000 after acquiring an additional 3,220 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.8%

XBI opened at $135.34 on Wednesday. The firm has a market cap of $8.63 billion, a PE ratio of 11.47 and a beta of 0.85. The business has a fifty day simple moving average of $132.91 and a 200-day simple moving average of $127.37. SPDR S&P Biotech ETF has a fifty-two week low of $80.90 and a fifty-two week high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.